| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |